SCOPUS 정보 검색 플랫폼

Volumn 684, Issue 1-3, 2012, Pages 154-160

NS-1: A novel partial peroxisome proliferator-activated receptor γ agonist to improve insulin sensitivity and metabolic profile

(5) Chaudhary, Sumit a Dube, Aakanksha a Kothari, Vishal a Sachan, Narsingh a Upasani, Chandrashekhar Devidas a

a Faculty of Pharmacy (India)

Author keywords

DIO, mouse; Insulin sensitizer; NS 1; Peroxisome proliferator activated receptor (PPAR)

Indexed keywords

4 [2 (4 ISOPROPYLBENZAMIDO)ETHOXY]BENZOIC ACID; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; PIRINIXIC ACID;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CELL ASSAY; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MAXIMUM PLASMA CONCENTRATION; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STAINING; TRANSACTIVATION; TREATMENT DURATION; WEIGHT GAIN;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; BODY WEIGHT; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MALE; METABOLOME; MICE; MICE, INBRED C57BL; NIH 3T3 CELLS; PPAR GAMMA; THIAZOLIDINEDIONES; THIAZOLIDINES;

EID: 84860838260 PISSN: 00142999 EISSN: 18790712 Source Type: Journal
DOI: 10.1016/j.ejphar.2012.03.033 Document Type: Article

Times cited : (6)

References (28)

1
- 12444273748
- Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator
- DOI 10.1210/me.2002-0217
- J.P. Berger, A.E. Petro, K.L. Macnaul, L.J. Kelly, B.B. Zhang, K. Richards, A. Elbrecht, B.A. Johnson, G. Zhou, and T.W. Doebber Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator Mol. Endocrinol. 17 2003 662 676 (Pubitemid 36403578)
- (2003) Molecular Endocrinology , vol.17 , Issue.4 , pp. 662-676
- Berger, J.P.¹ Petro, A.E.² Macnaul, K.L.³ Kelly, L.J.⁴ Zhang, B.B.⁵ Richards, K.⁶ Elbrecht, A.⁷ Johnson, B.A.⁸ Zhou, G.⁹ Doebber, T.W.¹⁰ Biswas, C.¹¹ Parikh, M.¹² Sharma, N.¹³ Tanen, M.R.¹⁴ Thompson, G.M.¹⁵ Ventre, J.¹⁶ Adams, A.D.¹⁷ Mosley, R.¹⁸ Surwit, R.S.¹⁹ Moller, D.E.²⁰ more..

2
- 18044376795
- PPARs: Therapeutic targets for metabolic disease
- DOI 10.1016/j.tips.2005.03.003
- J.P. Berger, T.E. Akiyama, and P.T. Meinke PPARs: therapeutic targets for metabolic disease Trends Pharmacol. Sci. 26 2005 244 251 (Pubitemid 40603072)
- (2005) Trends in Pharmacological Sciences , vol.26 , Issue.5 , pp. 244-251
- Berger, J.P.¹ Akiyama, T.E.² Meinke, P.T.³

3
- 0029981772
- Differential activation of adipogenesis by multiple PPAR isoforms
- R.P. Brun, P. Tontonoz, B.M. Forman, R. Ellis, J. Chen, R.M. Evans, and B.M. Spiegelman Differential activation of adipogenesis by multiple PPAR isoforms Genes Dev. 10 1996 974 984 (Pubitemid 26138708)
- (1996) Genes and Development , vol.10 , Issue.8 , pp. 974-984
- Brun, R.P.¹ Tontonoz, P.² Forman, B.M.³ Ellis, R.⁴ Chen, J.⁵ Evans, R.M.⁶ Spiegelman, B.M.⁷

4
- 0033305213
- Peroxisome proliferator-activated receptors: Nuclear control of metabolism
- B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr. Rev. 20 1999 649 688 (Pubitemid 30650602)
- (1999) Endocrine Reviews , vol.20 , Issue.5 , pp. 649-688
- Desvergne, B.¹ Wahli, W.²

5
- 26844499207
- Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo
- DOI 10.1080/13547500500218682
- F.L. Egerod, H.S. Nielsen, L. Iversen, I. Thorup, T. Storgaard, and M.B. Oleksiewicz Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo Biomarkers 10 2005 295 309 (Pubitemid 41448390)
- (2005) Biomarkers , vol.10 , Issue.4 , pp. 295-309
- Egerod, F.L.¹ Nielsen, H.S.² Iversen, L.³ Thorup, I.⁴ Storgaard, T.⁵ Oleksiewicz, M.B.⁶

6
- 84860838854
- FDA statistical review Available at http://www.fda.gov/ohrms/dockets/ac/ 05/briefing/2005-4169B2-02-07-FDA-Errata.pdf 2005
- (2005) FDA Statistical Review

7
- 84860839902
- September 9 2005. 64
- FDA advisory committee transcript on muraglitazar September 9 2005. 64, 47-49. Available at http://www.fda.gov/ohrms/dockets/ac/05/transcripts/2005- 4169T2.pdf
- FDA Advisory Committee Transcript on Muraglitazar , pp. 47-49

8
- 0037198679
- Transcription coactivator TRAP220 is required for PPARγ2-stimulated adipogenesis
- DOI 10.1038/417563a
- K. Ge, M. Guermah, C.X. Yuan, M. Ito, A.E. Wallberg, and B.M. Spiegelman Transcription coactivator TRAP220 is required for PPARγ-stimulated adipogenesis Nature 417 2002 563 567 (Pubitemid 34595925)
- (2002) Nature , vol.417 , Issue.6888 , pp. 563-567
- Ge, K.¹ Guermah, M.² Yuan, C.-X.³ Ito, M.⁴ Wallberg, A.E.⁵ Spiegelman, B.M.⁶ Roeder, R.G.⁷

9
- 33746111519
- KR-62980: A novel peroxisome proliferator-activated receptor γ agonist with weak adipogenic effects
- R.K. Kwang, H.L. Jeong, J.K. Seung, D.R. Sang, H.J. Won, D.Y. Sung, S.K. Sung, H.A. Jin, and C. Hyae KR-62980: a novel peroxisome proliferator-activated receptor γ agonist with weak adipogenic effects Biochem. Pharmacol. 72 2006 446 454
- (2006) Biochem. Pharmacol. , vol.72 , pp. 446-454
- Kwang, R.K.¹ Jeong, H.L.² Seung, J.K.³ Sang, D.R.⁴ Won, H.J.⁵ Sung, D.Y.⁶ Sung, S.K.⁷ Jin, H.A.⁸ Hyae, C.⁹

10
- 0036250329
- Differentiating members of the thiazolidinedione class: A focus on safety
- H.E. Lebovitz Differentiating members of the thiazolidinedione class: a focus on safety Diabetes Metab. Res. Rev. 2 Suppl. 18 2002 S23 S29
- (2002) Diabetes Metab. Res. Rev. , vol.2 , Issue.SUPPL. 18
- Lebovitz, H.E.¹

11
- 0029016829
- An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ
- J.M. Lehmann An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ J. Biol. Chem. 270 1995 12953 12956
- (1995) J. Biol. Chem. , vol.270 , pp. 12953-12956
- Lehmann, J.M.¹

12
- 0037960935
- PAT5A: A partial agonist of peroxisome proliferator-activated receptor γ is a potent antidiabetic thiazolidinedione yet weakly adipogenic
- DOI 10.1124/jpet.103.049791
- P. Misra, R. Chakrabarti, R.K. Vikramadithyan, G. Bolusu, S. Juluri, and J. Hiriyan PAT5A: a partial agonist of peroxisome proliferator-activated receptor γ is a potent antidiabetic thiazolidinedione yet weakly adipogenic J. Pharmacol. Exp. Ther. 306 2003 763 771 (Pubitemid 36886178)
- (2003) Journal of Pharmacology and Experimental Therapeutics , vol.306 , Issue.2 , pp. 763-771
- Misra, P.¹ Chakrabarti, R.² Vikramadithyan, R.K.³ Gopalakrishnan, B.⁴ Suresh, J.⁵ Jagadheshan, H.⁶ Cynthia, G.⁷ Rajjak, A.⁸ Kashireddy, P.⁹ Songtaoyu¹⁰ Surapureddi, S.¹¹ Qi, C.¹² Zhu, Y.-J.¹³ Rao, M.S.¹⁴ Reddy, J.K.¹⁵ Rajagopalan, R.¹⁶

13
- 0035056155
- Peroxisome proliferator-activated receptor (PPAR)γ agonists for diabetes
- DOI 10.1016/S0065-3233(01)56006-4
- D.E. Moller, and D.A. Greene Peroxisome proliferator-activated receptor (PPAR) γ agonists for diabetes Adv. Protein Chem. 56 2001 181 212 (Drug Discovery) (Pubitemid 32367459)
- (2001) Advances in Protein Chemistry , vol.56 , pp. 181-212
- Moller, D.E.¹ Greene, D.A.²

14
- 1542652476
- Thiazolidinediones, peripheral edema, and type 2 diabetes: Incidence, pathophysiology and clinical implications
- S. Mudaliar, A.R. Chang, and R.R. Henry Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology and clinical implications Endocr. Pract. 9 2003 406 416
- (2003) Endocr. Pract. , vol.9 , pp. 406-416
- Mudaliar, S.¹ Chang, A.R.² Henry, R.R.³

15
- 0033766035
- A selective peroxisome proliferator-activated receptor-γ (PPAR) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes
- R. Mukherjee, P.A. Hoener, L. Jow, J. Bilakovics, K. Klausing, and D.E. Mais A selective peroxisome proliferator-activated receptor-γ (PPAR) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes Mol. Endocrinol. 14 2000 1425 1433
- (2000) Mol. Endocrinol. , vol.14 , pp. 1425-1433
- Mukherjee, R.¹ Hoener, P.A.² Jow, L.³ Bilakovics, J.⁴ Klausing, K.⁵ Mais, D.E.⁶

16
- 14644427833
- The dual PPARα/γ agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats
- DOI 10.1038/sj.bjp.0706041
- L.C. Pickavance, C.L. Brand, K. Wassermann, and J.P. Wilding The dual PPAR α/ γ agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats Br. J. Pharmacol. 144 2005 308 316 (Pubitemid 40313676)
- (2005) British Journal of Pharmacology , vol.144 , Issue.3 , pp. 308-316
- Pickavance, L.C.¹ Brand, C.L.² Wassermann, K.³ Wilding, J.P.H.⁴

17
- 0032484224
- A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor γ activating properties
- M.J. Reginato, S.T. Bailey, S.L. Krakow, C. Minam, S. Ishii, and H. Tanaka A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor γ activating properties J. Biol. Chem. 273 1998 32679 326784
- (1998) J. Biol. Chem. , vol.273 , pp. 32679-326784
- Reginato, M.J.¹ Bailey, S.T.² Krakow, S.L.³ Minam, C.⁴ Ishii, S.⁵ Tanaka, H.⁶

18
- 2642557181
- A unique PPARγ ligand with potent insulin-sensitizing yet weak adipogenic activity
- DOI 10.1016/S1097-2765(01)00353-7
- S. Rocchi, F. Picard, J. Vamecq, L. Gelman, N. Potier, D. Zeyer, L. Dubuquoy, P. Bac, M.F. Champy, K.D. Plunket, L.M. Leesnitzer, S.G. Blanchard, P. Desreumaux, D. Moras, J.P. Renaud, and J. Auwerx A unique PPAR γ ligand with potent insulin-sensitizing yet weak adipogenic activity Mol. Cell 8 2001 737 747 (Pubitemid 33030208)
- (2001) Molecular Cell , vol.8 , Issue.4 , pp. 737-747
- Rocchi, S.¹ Picard, F.² Vamecq, J.³ Gelman, L.⁴ Potier, N.⁵ Zeyer, D.⁶ Dubuquoy, L.⁷ Bac, P.⁸ Champy, M.-F.⁹ Plunket, K.D.¹⁰ Leesnitzer, L.M.¹¹ Blanchard, S.G.¹² Desreumaux, P.¹³ Moras, D.¹⁴ Renaud, J.-P.¹⁵ Auwerx, J.¹⁶

19
- 39149105999
- Synthesis, antihyperglycemic activity and QSAR of 5-benzylidine-2, 4-thiazolidinediones
- N. Sachan, S.S. Kadam, and V.M. Kulkarni Synthesis, antihyperglycemic activity and QSAR of 5-benzylidine-2, 4-thiazolidinediones Indian J. Heterocycl. Chem. 17 2007 57 62
- (2007) Indian J. Heterocycl. Chem. , vol.17 , pp. 57-62
- Sachan, N.¹ Kadam, S.S.² Kulkarni, V.M.³

20
- 0035043970
- Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous
- DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q
- A. Sen, Y.R. Lea-Currie, D. Sujkowska, D.M. Franklin, W.O. Wilkison, and Y.D. Halvorsen Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous J. Cell. Biochem. 81 2001 312 319 (Pubitemid 32298263)
- (2001) Journal of Cellular Biochemistry , vol.81 , Issue.2 , pp. 312-319
- Sen, A.¹ Renee Lea-Currie, Y.² Sujkowska, D.³ Franklin, D.M.⁴ Wilkison, W.O.⁵ Halvorsen, Y.-D.C.⁶ Gimble, J.M.⁷

21
- 0034021443
- The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice
- A. Shimaya, E. Kurosaki, R. Nakano, R. Hirayama, M. Shibasaki, and H. Shikama The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice Metabolism 49 2000 411 417 (Pubitemid 30146575)
- (2000) Metabolism: Clinical and Experimental , vol.49 , Issue.3 , pp. 411-417
- Shimaya, A.¹ Kurosaki, E.² Nakano, R.³ Hirayama, R.⁴ Shibasaki, M.⁵ Shikama, H.⁶

22
- 0020353926
- Studies on antidiabetic agents. II. Synthesis of 5-[4-(1- methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives
- T. Sohda Studies on antidiabetic agents. Synthesis of 5-[4-(1 ethylcyclohexylmethoxy) benzyl]thiazolidine-2,4-dione (AD-3878) and its derivatives Chem. Pharm. Bull. 30 1982 3580 3600 (Pubitemid 13210097)
- (1982) Chemical and Pharmaceutical Bulletin , vol.30 , Issue.10 , pp. 3580-3600
- Sohda, T.¹ Mizuno, K.² Imamiya, E.³

23
- 23644456172
- Therapeutic roles of peroxisome proliferator-activated receptor agonists
- DOI 10.2337/diabetes.54.8.2460
- B. Staels, and J.C. Fruchart Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 54 2005 2460 2470 (Pubitemid 41134276)
- (2005) Diabetes , vol.54 , Issue.8 , pp. 2460-2470
- Staels, B.¹ Fruchart, J.-C.²

24
- 0028180070
- MPPAR γ 2: Tissue-specific regulator of an adipocyte enhancer
- P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman mPPAR γ 2: tissue-specific regulator of an adipocyte enhancer Genes Dev. 8 1994 1224 1234
- (1994) Genes Dev. , vol.8 , pp. 1224-1234
- Tontonoz, P.¹ Hu, E.² Graves, R.A.³ Budavari, A.I.⁴ Spiegelman, B.M.⁵

25
- 0030062325
- The structure-activity relationship between peroxisome proliferator-activated receptor-g agonism and the antihyperglycemic activity of the thiazolidinediones
- T.M. Willson, J.E. Cobb, D.J. Cowan, R.W. Wiehte, I.D. Correa, S.R. Prakash, K.D. Beck, L.B. Moore, S.A. Kliewer, and J.M. Lehmann The structure-activity relationship between peroxisome proliferator-activated receptor-g agonism and the antihyperglycemic activity of the thiazolidinediones J. Med. Chem. 39 1996 665 668
- (1996) J. Med. Chem. , vol.39 , pp. 665-668
- Willson, T.M.¹ Cobb, J.E.² Cowan, D.J.³ Wiehte, R.W.⁴ Correa, I.D.⁵ Prakash, S.R.⁶ Beck, K.D.⁷ Moore, L.B.⁸ Kliewer, S.A.⁹ Lehmann, J.M.¹⁰

26
- 0033998334
- The PPARs: From orphan receptors to drug discovery
- DOI 10.1021/jm990554g
- T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550 (Pubitemid 30127149)
- (2000) Journal of Medicinal Chemistry , vol.43 , Issue.4 , pp. 527-550
- Willson, T.M.¹ Brown, P.J.² Sternbach, D.D.³ Henke, B.R.⁴

27
- 0018800219
- Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion
- L.S. Wise, and H. Green Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion J. Biol. Chem. 254 1979 273 275
- (1979) J. Biol. Chem. , vol.254 , pp. 273-275
- Wise, L.S.¹ Green, H.²

28
- 0034085884
- A new thiazolidinedione, NC-2100, which is a weak PPAR-γ activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice
- F. Yuka, M. Sei-ichiro, O. Shiho, U. Kazuhiko, and M. Kiyoto A new thiazolidinedione, NC-2100, which is a weak PPAR-γ activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice Diabetes 49 2000 757 767
- (2000) Diabetes , vol.49 , pp. 757-767
- Yuka, F.¹ Sei-Ichiro, M.² Shiho, O.³ Kazuhiko, U.⁴ Kiyoto, M.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.